Atyr Pharma Inc (NASDAQ:ATYR) shares, rose in value on Wednesday, July 09, with the stock price up by 6.55% to the previous day’s close as strong demand from buyers drove the stock to $5.53.
Actively observing the price movement in the last trading, the stock closed the session at $5.19, falling within a range of $5.07 and $5.58. The value of beta (5-year monthly) was 0.874. Referring to stock’s 52-week performance, its high was $5.98, and the low was $1.51. On the whole, ATYR has fluctuated by 2.79% over the past month.
With the market capitalization of Atyr Pharma Inc currently standing at about $492.19 million, investors are eagerly awaiting this quarter’s results, scheduled for on 2025-May-07.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that ATYR’s technical picture suggests that short-term indicators denote the stock is a 100% Buy on average. However, medium-term indicators have put the stock in the category of 100% Buy while long-term indicators on average have been pointing out that it is a 100% Buy.
The stock’s technical analysis shows that the price of ATYR currently trading nearly 5.25% and 25.07% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 62.65, while the 7-day volatility ratio is showing 8.12% which for the 30-day chart, stands at 7.73%. Furthermore, Atyr Pharma Inc (ATYR)’s beta value is 0.95.
A comparison of Atyr Pharma Inc (ATYR) with its peers suggests the former has fared considerably weaker in the market. ATYR showed an intraday change of 6.55% in last session, and over the past year, it grew by 52.76%%.
Data on historical trading for Atyr Pharma Inc (NASDAQ:ATYR) indicates that the trading volumes over the past 10 days have averaged 4.89 and over the past 3 months, they’ve averaged 2.29 million. According to company’s latest data on outstanding shares, there are 89.00 million shares outstanding.
Nearly 3.31% of Atyr Pharma Inc’s shares belong to company insiders and institutional investors own 68.68% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 13.64 million shares as on 2025-06-13, resulting in a short ratio of 6.12. According to the data, the short interest in Atyr Pharma Inc (ATYR) stood at 1871.00 of shares outstanding as of 2025-06-13; the number of short shares registered in 2025-05-15 reached 12.68 million. The stock has risen by 266.23% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the ATYR stock heading into the next quarter.
